Detection of neoantigen-specific T cells following a personalized vaccine in a patient with glioblastoma
Neoantigens represent promising targets for personalized cancer vaccine strategies.
However, the feasibility of this approach in lower mutational burden tumors like glioblastoma …
However, the feasibility of this approach in lower mutational burden tumors like glioblastoma …
Detection of neoantigen-specific T cells following a personalized vaccine in a patient with glioblastoma
TM Johanns, CA Miller, CJ Liu, RJ Perrin… - …, 2019 - pubmed.ncbi.nlm.nih.gov
Neoantigens represent promising targets for personalized cancer vaccine strategies.
However, the feasibility of this approach in lower mutational burden tumors like glioblastoma …
However, the feasibility of this approach in lower mutational burden tumors like glioblastoma …
Detection of neoantigen-specific T cells following a personalized vaccine in a patient with glioblastoma
TM Johanns, CA Miller, CJ Liu, RJ Perrin… - …, 2019 - profiles.wustl.edu
Neoantigens represent promising targets for personalized cancer vaccine strategies.
However, the feasibility of this approach in lower mutational burden tumors like glioblastoma …
However, the feasibility of this approach in lower mutational burden tumors like glioblastoma …
[引用][C] Detection of neoantigen-specific T cells following a personalized vaccine in a patient with glioblastoma
TM Johanns, CA Miller, CJ Liu, RJ Perrin, D Bender… - …, 2019 - cir.nii.ac.jp
Detection of neoantigen-specific T cells following a personalized vaccine in a patient with
glioblastoma | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 …
glioblastoma | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 …
[HTML][HTML] Detection of neoantigen-specific T cells following a personalized vaccine in a patient with glioblastoma
TM Johanns, CA Miller, CJ Liu, RJ Perrin… - …, 2019 - ncbi.nlm.nih.gov
Neoantigens represent promising targets for personalized cancer vaccine strategies.
However, the feasibility of this approach in lower mutational burden tumors like glioblastoma …
However, the feasibility of this approach in lower mutational burden tumors like glioblastoma …
Detection of neoantigen-specific T cells following a personalized vaccine in a patient with glioblastoma
TM Johanns, CA Miller, CJ Liu, RJ Perrin, D Bender… - 2019 - digitalcommons.wustl.edu
Neoantigens represent promising targets for personalized cancer vaccine strategies.
However, the feasibility of this approach in lower mutational burden tumors like glioblastoma …
However, the feasibility of this approach in lower mutational burden tumors like glioblastoma …
Detection of neoantigen-specific T cells following a personalized vaccine in a patient with glioblastoma.
TM Johanns, CA Miller, CJ Liu, RJ Perrin… - …, 2019 - europepmc.org
Neoantigens represent promising targets for personalized cancer vaccine strategies.
However, the feasibility of this approach in lower mutational burden tumors like glioblastoma …
However, the feasibility of this approach in lower mutational burden tumors like glioblastoma …
Detection of neoantigen-specific T cells following a personalized vaccine in a patient with glioblastoma
TM Johanns, CA Miller, CJ Liu, RJ Perrin… - …, 2019 - ohiostate.elsevierpure.com
Neoantigens represent promising targets for personalized cancer vaccine strategies.
However, the feasibility of this approach in lower mutational burden tumors like glioblastoma …
However, the feasibility of this approach in lower mutational burden tumors like glioblastoma …
[PDF][PDF] Detection of neoantigen-specific T cells following a personalized vaccine in a patient with glioblastoma
TM Johanns, CA Miller, CJ Liu, RJ Perrin, D Bender… - 2019 - academia.edu
Neoantigens represent promising targets for personalized cancer vaccine strategies.
However, the feasibility of this approach in lower mutational burden tumors like glioblastoma …
However, the feasibility of this approach in lower mutational burden tumors like glioblastoma …
[PDF][PDF] Detection of neoantigen-specific T cells following a personalized vaccine in a patient with glioblastoma
TM Johanns, CA Miller, CJ Liu, RJ Perrin, D Bender - core.ac.uk
Neoantigens represent promising targets for personalized cancer vaccine strategies.
However, the feasibility of this approach in lower mutational burden tumors like glioblastoma …
However, the feasibility of this approach in lower mutational burden tumors like glioblastoma …